ORMP: Advancing Clinical Activities
ORMP is leveraging its strong balance sheet to invest in early stage companies, primarily focusing on the medical & biopharma space. ORMP has...
208 Views
ORMP: With Substantial Liquidity, ORMP Has Generated Gains & Income From Investment Portfolio
Among the investments ORMP has made, it provided collateralized financing to Scilex Holding and received a promissory note collateralized by...
197 Views
ORMP: Upcoming Expected Milestones Include OraTech Spin-Off & IPO, Launch of Phase 3 Trial
OraTech will leverage HTIT's manufacturing capabilities and focus on developing and commercializing innovative products globally based on ORMP's...
199 Views
ORMP: Preparations for New Phase 3 Trial Advance
ORMP is leveraging its strong balance sheet - ~$142m in cash, equivalents, ST investments & deposits, no LT debt - to optimize its cash...
192 Views
ORMP: Balance Sheet Strong, Potential Benefits of Investments, JVs, Buybacks
The company's discussions with the FDA progress as ORMP plans to launch a Phase 3 oral insulin trial in the U.S. under a differentiated protocol...
232 Views